Published on

Medicine – CDC Classification of HIV/AIDS

Human immunodeficiency virus (HIV) infection can progress from an acute primary illness to prolonged clinical latency and eventually advanced immunodeficiency, known as acquired immunodeficiency syndrome (AIDS).

The traditional four-stage clinical progression model describes the natural history of untreated HIV infection. However, it should be distinguished from the modern CDC HIV surveillance classification, which primarily uses CD4 count and the presence of AIDS-defining illnesses.

Important Distinction

The traditional four-stage sequence is a historical clinical progression model, whereas the modern CDC surveillance system uses stages 0–3, with an additional unknown classification when staging information is insufficient.

1. Traditional Four-Stage Clinical Progression of HIV

The traditional model divides HIV infection into four clinical phases:

  1. Primary seroconversion illness.
  2. Asymptomatic phase.
  3. Persistent generalised lymphadenopathy.
  4. AIDS.

Illustration: Traditional Clinical Progression

Stage 1 Primary Seroconversion Illness Acute HIV infection Stage 2 Asymptomatic Phase Clinical latency Stage 3 Persistent Generalised Lymphadenopathy Stage 4 AIDS Advanced immunodeficiency Simplified historical teaching sequence.

Persistent generalised lymphadenopathy may occur during the asymptomatic phase and is not necessarily a separate sequential stage.

2. Stage 1 – Primary Seroconversion Illness

Primary seroconversion illness represents the initial phase following HIV acquisition, usually developing approximately 2–4 weeks after infection.

During this phase, viral replication is extremely active, producing high plasma HIV RNA levels and increased infectiousness.

Clinical Features

  • Fever.
  • Sore throat.
  • Generalised lymphadenopathy.
  • Maculopapular rash.
  • Myalgia and arthralgia.
  • Headache.
  • Malaise.
  • Occasionally aseptic meningitis.

The CD4 count may decrease transiently before partially recovering.

Illustration: Acute HIV Seroconversion

Recent HIV Infection Early viral replication High HIV RNA High infectiousness Acute Symptoms Fever, rash, sore throat Partial Immune Recovery
Examination Point: Acute HIV infection may resemble infectious mononucleosis or influenza. HIV RNA testing is particularly important when acute infection is suspected.

3. Stage 2 – Asymptomatic Phase (Clinical Latency)

Following acute infection, the patient may remain clinically asymptomatic for several years.

Without treatment, the historical median time from HIV acquisition to AIDS was approximately 8–10 years, although progression varies substantially between individuals.

Important Characteristics

  • Few or no symptoms.
  • Persistent HIV replication despite the absence of symptoms.
  • Gradual decline in CD4+ T-cell count.
  • Progressive immune dysfunction.
  • Ongoing risk of HIV transmission without viral suppression.

The term clinical latency does not mean that HIV is biologically inactive.

Illustration: Untreated HIV – Viral Load and CD4 Count

Natural History of Untreated HIV High Low Acute Clinical Latency AIDS Viral load CD4 count

Conceptual trends only; not a quantitative or patient-specific graph. Effective ART substantially alters this natural history.

Examination Point: Patients may appear healthy for years while HIV continues to replicate and gradually damages the immune system.

4. Stage 3 – Persistent Generalised Lymphadenopathy (PGL)

Persistent generalised lymphadenopathy refers to enlargement of lymph nodes at two or more noncontiguous extra-inguinal sites for at least three months, without another identifiable cause.

Common Sites

  • Cervical lymph nodes.
  • Axillary lymph nodes.
  • Occipital lymph nodes.

Clinical Features

  • Enlarged lymph nodes.
  • Usually symmetrical distribution.
  • Frequently painless.
  • Often rubbery or firm.
  • May occur without constitutional symptoms.

PGL results largely from persistent immune stimulation and lymphoid tissue changes associated with HIV infection.

It may coexist with the asymptomatic phase rather than occurring strictly after it.

Illustration: Common Sites of Generalised Lymphadenopathy

Cervical nodes Axillary nodes Schematic lymph node locations.
Examination Point: Persistent generalised lymphadenopathy is a recognised manifestation of HIV infection but is not, by itself, an AIDS-defining illness.

5. Stage 4 – AIDS

AIDS represents advanced HIV infection with substantial immune dysfunction.

It may be diagnosed through recognised AIDS-defining conditions or immunological criteria.

Common AIDS-Defining Illnesses

  • Pneumocystis jirovecii pneumonia.
  • Oesophageal candidiasis.
  • Pulmonary or extrapulmonary tuberculosis.
  • Cerebral toxoplasmosis.
  • Cryptococcal meningitis.
  • Cytomegalovirus retinitis.
  • Kaposi sarcoma.
  • Progressive multifocal leukoencephalopathy.
  • Certain non-Hodgkin lymphomas.

Clinical Manifestations of Advanced HIV

  • Severe opportunistic infections.
  • Persistent fever.
  • Significant weight loss.
  • Chronic diarrhoea.
  • Neurological dysfunction.
  • HIV-associated malignancies.
Examination Point: An AIDS-defining illness can establish an AIDS diagnosis regardless of the patient's CD4 count.

6. Modern CDC Classification of HIV Infection

The modern CDC surveillance classification for adults and adolescents uses three numbered stages, with an additional stage 0 for documented recent HIV infection.

An unknown stage is used when sufficient staging information is unavailable.

CDC Surveillance Staging Table

CDC Stage CD4 Count (cells/mm³) CD4 Percentage Clinical Significance
Stage 0 Not determined by CD4 Not determined by CD4 Documented recent HIV infection meeting specified testing criteria
Stage 1 ≥500 ≥26% Relatively preserved immunity
Stage 2 200–499 14–25% Moderate immunosuppression
Stage 3 (AIDS) Below 200 Below 14% Severe immunosuppression or AIDS-defining illness

CD4 percentage is used for surveillance staging when an absolute CD4 count is unavailable. An AIDS-defining illness establishes stage 3 regardless of CD4 count. Paediatric CD4 thresholds differ.

Illustration: Modern CDC Staging by CD4 Count

CDC CD4-Based Staging Stage 1 CD4 ≥500 cells/mm³ Stage 2 CD4 200–499 cells/mm³ Stage 3 – AIDS CD4 <200 cells/mm³ An AIDS-defining illness also establishes stage 3.

Stage 0 is based on documented recent infection rather than a CD4 threshold.

7. Traditional Versus Modern CDC Classification

Traditional Clinical Progression Modern CDC Surveillance Classification
Stage 1: Primary seroconversion illness Stage 0 may identify documented recent infection
Stage 2: Asymptomatic phase Stage 1, 2 or 3 depending on immune status
Stage 3: Persistent generalised lymphadenopathy Not a separate numbered CDC stage
Stage 4: AIDS Stage 3 (AIDS)

The traditional model describes the clinical course of untreated HIV, whereas the modern CDC system classifies the degree of immunosuppression and AIDS-defining disease.

8. High-Yield Examination Summary

Traditional Four-Phase Model

  • Stage 1: Primary seroconversion illness.
  • Stage 2: Asymptomatic phase, historically lasting approximately 8–10 years before AIDS without treatment.
  • Stage 3: Persistent generalised lymphadenopathy.
  • Stage 4: AIDS.

Modern CDC Surveillance Staging

  • Stage 0: Documented recent HIV infection under specified testing criteria.
  • Stage 1: CD4 ≥500 cells/mm³.
  • Stage 2: CD4 200–499 cells/mm³.
  • Stage 3: CD4 below 200 cells/mm³ or an AIDS-defining illness.

Important Clinical Points

  • Acute HIV may resemble infectious mononucleosis.
  • Clinical latency does not mean absence of viral replication.
  • Persistent generalised lymphadenopathy is not itself AIDS-defining.
  • AIDS-defining illnesses may occur regardless of CD4 count.
  • Effective ART prevents progression and preserves immune function.
Most Important Examination Point

The traditional four-stage sequence in older medical notes is not the current CDC surveillance staging system. Modern CDC staging uses CD4 count and AIDS-defining illnesses, with stage 3 corresponding to AIDS.

Clinical Note

With modern antiretroviral therapy, progression to AIDS can usually be prevented through sustained viral suppression and immune preservation. The CDC classification is intended for surveillance and should not replace individual clinical assessment.

Kembara Xtra – Medicine Revision Notes

Image description
0 Comments